首页> 外国专利> LIPOPHILIC MURAMYL-PEPTIDES; PEPTIDE INTERMEDIATES; PHARMACEUTICAL COMPOSITIONS; FEEDSTUFFS AND FEEDSTUFF ADDITIVES COMPRISING ANTIBIOTIC AND MURAMYL-PEPTIDE

LIPOPHILIC MURAMYL-PEPTIDES; PEPTIDE INTERMEDIATES; PHARMACEUTICAL COMPOSITIONS; FEEDSTUFFS AND FEEDSTUFF ADDITIVES COMPRISING ANTIBIOTIC AND MURAMYL-PEPTIDE

机译:脂族甲基肽;肽中间体药物成分;包含抗菌肽和缩甲基肽的饲料和饲料添加剂

摘要

Described are derivatives of pyranoses of the formula I, manufacturing processes and intermediates, and their use as medicaments. IMAGE (I) The pyranose moiety in the compounds of the formula I is derived especially from D-glucose, but alternatively from D-galactose or D-mannose. Characteristic of the compounds of the formula I is the lower alkyl or phenyl-lower alkyl radical R8, which carries an oxycarbonyl, mercaptocarbonyl or aminocarbonyl group, which is bonded to an aliphatic, cycloaliphaticaliphatic, cycloaliphatic or aromatic hydrocarbon radical R0, each of which is optionally substituted and which may be interrupted by oxycarbonyl, mercaptocarbonyl and/or iminocarbonyl and which, like the remaining radicals of the formula I, is defined in patent claim 1.
机译:描述了式I的吡喃糖酶的衍生物,制造方法和中间体,以及它们作为药物的用途。 <图像>(I)式I的化合物中的吡喃糖部分特别衍生自D-葡萄糖,但可选地衍生自D-半乳糖或D-甘露糖。式I化合物的特征是带有氧羰基,巯基羰基或氨基羰基的低级烷基或苯基-低级烷基基团R8,该基团与脂族,脂环族脂族,脂环族或芳族烃基R0键合,每个基团为任选地被取代并且可以被氧羰基,巯基羰基和/或亚氨基羰基中断,并且与式I的其余基团一样,在专利权利要求1中定义。

著录项

  • 公开/公告号NZ196261A

    专利类型

  • 公开/公告日1984-05-31

    原文格式PDF

  • 申请/专利权人 CIBA-GEIGY A.G.;

    申请/专利号NZ19810196261

  • 申请日1981-02-13

  • 分类号C07C103/00;C07H15/00;A61K37/02;A23K1/17;

  • 国家 NZ

  • 入库时间 2022-08-22 09:14:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号